Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Plasmodium vivax Merozoite Surface Protein 1 (MSP1) Monoclonal Antibody

Cat. No.VD7N82

Product TypeVeterinary Antibodies

Size 1 mg

Product Overview

BioVenic mouse monoclonal antibody is specific for Plasmodium vivax merozoite surface protein 1. It is affinity purified by protein A. It can be applied to ELISA and WB of Plasmodium vivax merozoite surface protein 1.

Specifications

Application ELISA; WB
Clonality Monoclonal
Classification Primary Antibody
Clone L10N27
Host Mouse
Target Species Parasite
Species Reactivity Parasite
Specificity Plasmodium vivax Merozoite Surface Protein 1
Isotype IgG1
Purification Protein A Purified
Purity > 90%
Conjugation Unconjugated
Preservative and Stabilizer 0.09% Sodium Azide
Buffer Phosphate Buffered Saline, 7.2
Physical State Liquid

Target Information

Plasmodium vivax merozoite surface protein 1 (MSP1) is a prominent surface antigen of the Plasmodium vivax parasite, which is a causative agent of one of the prevalent forms of human malaria, particularly in South and Southeast Asia, the Americas, and Oceania. MSP1 plays a crucial role in the invasion of red blood cells by the merozoite stage of the parasite and is a target for both diagnostic and vaccine development efforts.

Target Plasmodium vivax Merozoite Surface Protein 1
Target Synonym Major surface protein 1
Taxonomy ID 5855

Shipping and Storage

This product is shipped with dry ice packs. Store at -80°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Versiani, Fernanda G., et al. "N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine." Journal of Immunology Research 2013.1 (2013): 965841.
Inquiry Basket